Makaleler
18
Tümü (18)
SCI-E, SSCI, AHCI (18)
SCI-E, SSCI, AHCI, ESCI (18)
Scopus (18)
8. Targeting SARS-CoV-2 Nsp12/Nsp8 interaction interface with approved and investigational drugs: an in silico structure-based approach
Journal of Biomolecular Structure and Dynamics
, cilt.40, sa.2, ss.918-930, 2022 (SCI-Expanded, Scopus)
12. Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13)
International Journal of Biological Macromolecules
, cilt.163, ss.1687-1696, 2020 (SCI-Expanded, Scopus)
14. Functional analyses of dipeptide and pentapeptide insertions on Theileria annulata enolase by site-directed mutagenesis and in silico approaches
Biochimica et Biophysica Acta - Proteins and Proteomics
, cilt.1867, sa.7-8, ss.732-739, 2019 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
29
4. Hit identification against Acinetobacter baumannii FabB via virtual screening, molecular dynamics simulation, and free energy calculations
Royal Society of Chemistry, Chemical Biology Symposium 2022, Londrina, Brezilya, 09 Mayıs 2022, cilt.207890, ss.1-77, (Özet Bildiri)
5. Drug repositioning to identify SARS-CoV-2 Nsp12/Nsp8 interaction interface inhibitors.
FEMS 2020 ONLINE CONFERENCE, Sırbistan, 28 - 31 Ekim 2020, (Özet Bildiri)
7. Evaluation of Plasmodium vivax and Theileria annulata LDH in Diagnosis
Eurasian Congress of Molecular Biotechnology (ECOMB 2019), Trabzon, Türkiye, 19 - 21 Eylül 2019, (Özet Bildiri)
8. Investigation of Bacteroides fragilis Enolase Inhibitors Using in silico Methods
Eurasian Congress of Molecular Biotechnology (ECOMB 2019), Trabzon, Türkiye, 19 - 21 Eylül 2019, (Özet Bildiri)
9. Bacteriodes Fragillis Enolaz Inhibitorü Belirlenmesine Yönelik Sanal Ligand Tarama Ve Moleküler Yanaştırma Çalışmaları
31. Ulusal Kimya Kongresi, İstanbul, Türkiye, 10 - 13 Eylül 2019, (Özet Bildiri)
10. Plasmodium vivax LDH’Inın Tanı Kiti Geliştirilmesi Amacıyla Saflaştırılması
31. Ulusal Kimya Kongresi, İstanbul, Türkiye, 10 - 13 Eylül 2019, (Özet Bildiri)
11. A Structure-Based Drug Design Study Interactions of Bos taurus Enolase and Coumarin Derivatives Through Molecular Docking and Molecular Dynamic Simulation
6th International BAU Drug Design Congress, Istanbul, Turkey, 13 - 15 Aralık 2018
12. Comparative Modelling and Molecular Dynamic Simulation of Bacteriodes fragillis Enolase
6th International BAU Drug Design Congress, Istanbul, Turkey, 13 - 15 Aralık 2018
13. Cloning, heterologous expression and purification of Toxoplasma gondii FabG (3-oxoacyl-[acyl-carrier-protein] reductase) enzyme
1.Euroasia Biochemical Approaches Technologies Congress (EBAT 2018), Antalya, Turkey, Türkiye, 27 - 30 Ekim 2018, (Özet Bildiri)
15. Biyo-Aktif Polimerler ile Biyolojik Moleküllere Dayalı Tanı ve Tedavi Yöntemlerinin Ultra-Hızlı Biyoortogonal Tepkimelerle Geliştirilmesi
6. Ulusal Biyomühendislik Öğrenci Kongresi,İstanbul, 5-6 Nisan 2018, Türkiye, 5 - 06 Nisan 2018, (Özet Bildiri)
16. Trichomonas vaginalis Tedavisinde in silico Analizlerle Yeni Aday İlaçların Belirlenmesi İçin 14-3-3 Proteininin Modellenmesi
19. UluslararasıKatılımlı Ulusal Biyoteknoloji Kongresi, Eskişehir, 1 -3 Aralık 2017., Türkiye, 1 - 03 Aralık 2017, (Özet Bildiri)
17. In silico Analyses of both Wild Type and Mutant TaPIN1 towards New Drug Discovery
5th International BAU-Drug Design Congress, Istanbul, Turkey, 19 - 21 Ekim 2017
18. Preparation of Concanavalin a Decorated P(PEGMA-co-NMAS) Polymeric Surfaces and Utilization in Bacterial Cell Detection
APME 17 Advanced Polymers via Macromolecular Engineering, Ghent, Belgium, 21 - 25 Mayıs 2017
19. Cloning of Peptiyl Prolyl cis/trans Isomerase from Theileria annulata
IVEK 3 rd International Convention of Pharmaceuticals and Pharmacies, Istanbul, Turkey, 26 - 29 Nisan 2017
20. Using an Alternatie System to Improve Expression Level of Recombinant Lactate Dehydrogenase from Plasmodium vivax
IVEK 3 rd International Convention of Pharmaceuticals andPharmacies, Istanbul, Turkey, 26 - 29 Nisan 2017
21. Molecular docking analyses of coumarin derivatives as Theileria annulata enolase inhibitors
5th International BAU-Drug Design Congress, Istanbul, Turkey, 19 Ekim - 21 Nisan 2017
22. Comprehensive Computational Analysis of Theileria annulata Enolase by Comparative Modeling and Docking
17th European Congress on Biotechnology, Krakow, Poland, 3 - 06 Temmuz 2016
23. Theileria annulata’nın Laktat Dehidrogenaz Enziminin Optimum pH Değerinin Belirlenmesi ve Termal Stabilite Analizi
4. UlusalMoleküler Biyoloji ve Biyoteknoloji Kongresi, Afyon, 21 -24 Ağustos 2015., Türkiye, 21 - 24 Ağustos 2015, (Özet Bildiri)
24. Theileria annulata Enolaz Enziminin Uygun Stabilizatörler Kullanılarak Depolama Koşullarının Belirlenmesi
4. Ulusal Moleküler Biyoloji ve Biyoteknoloji Kongresi, Afyon, 21 -24 Ağustos 2015., Türkiye, 21 - 24 Ağustos 2015, (Özet Bildiri)
25. Optimum pH Determination and Thermostability Analysis of Recombinant Fusobacterium nucleatum Enolase Enzyme
International Symposium on Molecular Chemistry, Istanbul, Turkey, 19 Aralık 2014
26. Fusobacterium nucleatum’xxun enolaz enziminin yüksek saflıkta üretilmesi
22. Ulusal Biyoloji Kongresi, Eskişehir, 23-27 Haziran 2014, Türkiye, 23 - 27 Haziran 2014, (Özet Bildiri)
27. Kinetic evaluation of enolase enzyme from Fusobacterium nucleatum towards new drug design studies
2nd International BAU-Drug Design Congress, Istanbul, Turkey, 17 - 19 Nisan 2014
28. Fusobacterium nucleatum Enolaz Enziminin Moleküler Modelinin Oluşturulması
2. İlaç Kimyası, Üretimi, Teknolojisi ve Standardizasyonu Kongresi, Türkiye, 21 - 23 Mart 2014, (Özet Bildiri)
29. Cloning and sequence analysis of enolase gene from Fusobacterium nucleatum
2nd International Congress of Molecular Biology Association of Turkey, Istanbul, Turkey, 22 - 23 Kasım 2013